The increasing prevalence and complexity of metastatic bone disease presenting to orthopaedic trauma units in the United Kingdom is a challenge shared by all hospitals. Recent updates to clinical guidelines, new advances in surgical techniques & technology and minimally invasive procedures will be discussed as well as the results of a recent national audit which have led to the first clinical trial in surgically treated metastatic bone patients in the UK.
Jonathan Stevenson is a specialist in orthopaedic oncology & arthroplasty at the Royal Orthopaedic Hospital, Birmingham. After graduating from the University of Birmingham with degrees in biomedical sciences and medicine in 2005, he undertook postgraduate orthopaedic training on the Stoke/Oswestry rotation in the West Midlands. He was awarded the British Orthopaedic Association (BOA) International travelling fellowship award, the British Orthopaedic Oncology Society European travelling fellowship award and the American-British-Canadian travelling fellowship. He has also completed the BOA clinical leadership programme and was awarded a certificate in strategic management and leadership.
Jonathan specialises in paediatric and adult bone and soft-tissue sarcomas, limb-salvage and complex arthroplasty, particularly prosthetic joint infection. He is a senior honorary clinical lecturer in orthopaedics at Aston University. Jonathan is chief/principal investigator on studies concerning metastatic bone disease, osseointegration of endoprosthetic replacements and bacterial fluorescence in PJI and clinical lead for sarcoma genomics, metastatic bone disease and the research tissue bank.
The presentation is part of the OncoEng Seminar Series sponsored by the Oncological Engineering Programme Grant which comprises the Universities of Birmingham, UCL, Imperial and Leeds in the UK. This work was supported by the Engineering and Physical Sciences Research Council in teh UK [grant number EP/W007096/1]